CompletedPhase 2NCT00657605
Effects of Human Leptin Replacement
Studying Neonatal diabetes mellitus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Miami
- Principal Investigator
- Julio Licinio, MDUniversity of Miami
- Intervention
- Recombinant methionyl human leptin(drug)
- Enrollment
- 3 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2001 – 2010
Study locations (1)
- University of Miami Miller School of Medicine, Center on Pharmacogenomics, Miami, Florida, United States
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00657605 on ClinicalTrials.govOther trials for Neonatal diabetes mellitus
Additional recruiting or active studies for the same condition.